Vaccine Go-To-Market Strategies in Brazil

CHALLENGE

Our client, a global strategy consulting firm, sought to develop a comprehensive go-to-market strategy for a specific disease vaccine in Brazil. To achieve this, they needed insights from individuals with recent and direct experience in the Brazilian vaccine landscape. The focus was on understanding market dynamics, regulatory requirements, procurement processes, and distribution channels within the country.

BTHT APPROACH

Our research team promptly started identifying and connecting with a diverse group of experts who possess in-depth knowledge and practical experience in Brazil's vaccine sector. Our team targeted professionals who had played pivotal roles in vaccine recommendation, procurement, distribution, and commercialization. We provided a curated pipeline of experts, including:

• Former decision-makers from the Ministry of Health, ANVISA (National Health Surveillance Agency), and CONITEC,
• Key Opinion Leaders (KOLs) from the Brazilian Immunization Society (SBIm) and the Centers for Disease Control and Prevention,
• Experts experienced in the management and monitoring of national and regional vaccine distributors and networks,
• Former commercial and vaccine business unit heads from leading pharmaceutical companies.

By facilitating connections with these seasoned professionals, we enabled our client to gather comprehensive and actionable insights during 1 hour consultations.

OUTCOME

By leveraging our expert network, the client gained a 360-degree view of the Brazilian vaccine market. Our team provided critical experts who have insights into the regulatory environment, reimbursement landscape, healthcare provider dynamics, and consumer behavior. The client was equipped with the knowledge and tools necessary to develop a tailored go-to-market strategy that maximized the vaccine's potential in the Brazilian market.